A new antigen test device for rapid influenza A and B detection.

Introduction: Tests for detection of influenza must demonstrate high sensitivity and specificity, affordability, and rapidness.

Methods: This study aimed to evaluate the performance of the LabOn-Time™ Influenza A + B Rapid test device (BMT Diagnostics, Ltd), as compared to Real-time polymerase chain reaction (RT-PCR), in identifying influenza A/B among 183 nasopharyngeal samples collected between February and April 2023 from patients with Influenza-like symptoms.

Results: Out of 70 participants with a positive RT-PCR result, 53 (75.